Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade. Editorial Article uri icon

Overview

publication date

  • July 13, 2017

Identity

PubMed Central ID

  • PMC5665085

Scopus Document Identifier

  • 85026853583

Digital Object Identifier (DOI)

  • 10.1080/2162402X.2017.1346766

PubMed ID

  • 29123961

Additional Document Info

volume

  • 6

issue

  • 10